Related Experiment Video
Updated: Dec 14, 2025

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network
Afnan Abu-Thuraia1,2, Marie-Anne Goyette1,2, Jonathan Boulais1
1Montreal Clinical Research Institute (IRCM), Montréal, QC, H2W 1R7, Canada.
Abstract:
Aberrant expression of receptor tyrosine kinase AXL is linked to metastasis. AXL can be activated by its ligand GAS6 or by other kinases, but the signaling pathways conferring its metastatic activity are unknown. Here, we define the AXL-regulated phosphoproteome in breast cancer cells. We reveal that AXL stimulates the phosphorylation of a network of focal adhesion (FA) proteins, culminating in faster FA disassembly. Mechanistically, AXL phosphorylates NEDD9, leading to its binding to CRKII which in turn associates with and orchestrates the phosphorylation of the pseudo-kinase PEAK1. We find that PEAK1 is in complex with the tyrosine kinase CSK to mediate the phosphorylation of PAXILLIN. Uncoupling of PEAK1 from AXL signaling decreases metastasis in vivo, but not tumor growth. Our results uncover a contribution of AXL signaling to FA dynamics, reveal a long sought-after mechanism underlying AXL metastatic activity, and identify PEAK1 as a therapeutic target in AXL positive tumors.
Insights
Aberrant AXL receptor tyrosine kinase signaling drives breast cancer metastasis by promoting focal adhesion disassembly. Targeting PEAK1 kinase may inhibit AXL-driven cancer spread.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Aberrant expression of receptor tyrosine kinase AXL is implicated in cancer metastasis.
- The specific signaling pathways through which AXL promotes metastasis remain largely undefined.
Purpose of the Study:
- To elucidate the AXL-regulated phosphoproteome in breast cancer cells.
- To identify the molecular mechanisms linking AXL signaling to cancer metastasis.
Main Methods:
- Phosphoproteomic analysis of breast cancer cells.
- Co-immunoprecipitation assays to identify protein complexes.
- In vivo metastasis assays.
Main Results:
- AXL activation phosphorylates focal adhesion proteins, accelerating focal adhesion disassembly.
- AXL signaling phosphorylates NEDD9, which binds CRKII, leading to PEAK1 phosphorylation.
- PEAK1, in complex with CSK, phosphorylates PAXILLIN, promoting metastasis.
- Disrupting the PEAK1-AXL interaction reduces metastasis but not tumor growth.
Conclusions:
- AXL signaling contributes to focal adhesion dynamics and cancer cell metastasis.
- A novel signaling axis involving AXL, NEDD9, CRKII, PEAK1, CSK, and PAXILLIN mediates AXL's metastatic activity.
- PEAK1 represents a potential therapeutic target for AXL-positive tumors.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Cancer Cell Migration through Invadopodia
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Cell Migration
Cell Migration

